Open-Label Dose Optimization of Methylphenidate Modified Release Long Acting (MPH-LA): A Post Hoc Analysis of Real-Life Titration from a 40-Week Randomized Trial

BACKGROUND AND OBJECTIVES: In the management of attention-deficit hyperactivity disorder (ADHD) in adults it is important to recognize that individual patients respond to a wide range of methylphenidate doses. Studies with methylphenidate modified release long acting (MPH-LA) in children have report...

Descripción completa

Detalles Bibliográficos
Autores principales: Huss, Michael, Ginsberg, Ylva, Arngrim, Torben, Philipsen, Alexandra, Carter, Katherine, Chen, Chien-Wei, Gandhi, Preetam, Kumar, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143596/
https://www.ncbi.nlm.nih.gov/pubmed/25015027
http://dx.doi.org/10.1007/s40261-014-0213-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143596/
https://www.ncbi.nlm.nih.gov/pubmed/25015027
http://dx.doi.org/10.1007/s40261-014-0213-2

Ejemplares similares